塩酸サルポグレラートによる末梢動脈閉塞症に対する微小循環の改善
塩酸サルポグレラートが末梢循環に及ぼす影響を評価した。末梢動脈閉塞症13例を対象とし,非服用時の患肢足背部の経皮酸素分圧(tcPO2)値が50 mmHg未満12肢(A群)と50 mmHg以上(B群)14肢の2群に分類し,内服前後のtcPO2値を評価した。A群の内服前後と初回内服前と2週間後以降の投与前のtcPO2値で有意差を認めた。tcPO2値50 mmHg以下の末梢循環で投与効果が得られた。...
Saved in:
Published in | 脈管学 Vol. 52; no. May; pp. 243 - 246 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | Japanese |
Published |
日本脈管学会
10.05.2012
|
Subjects | |
Online Access | Get full text |
ISSN | 0387-1126 1880-8840 |
DOI | 10.7133/jca.52.243 |
Cover
Abstract | 塩酸サルポグレラートが末梢循環に及ぼす影響を評価した。末梢動脈閉塞症13例を対象とし,非服用時の患肢足背部の経皮酸素分圧(tcPO2)値が50 mmHg未満12肢(A群)と50 mmHg以上(B群)14肢の2群に分類し,内服前後のtcPO2値を評価した。A群の内服前後と初回内服前と2週間後以降の投与前のtcPO2値で有意差を認めた。tcPO2値50 mmHg以下の末梢循環で投与効果が得られた。 |
---|---|
AbstractList | 塩酸サルポグレラートが末梢循環に及ぼす影響を評価した。末梢動脈閉塞症13例を対象とし,非服用時の患肢足背部の経皮酸素分圧(tcPO2)値が50 mmHg未満12肢(A群)と50 mmHg以上(B群)14肢の2群に分類し,内服前後のtcPO2値を評価した。A群の内服前後と初回内服前と2週間後以降の投与前のtcPO2値で有意差を認めた。tcPO2値50 mmHg以下の末梢循環で投与効果が得られた。 |
Author | 工藤, 敏文 豊福, 崇浩 地引, 政利 井上, 芳徳 |
Author_xml | – sequence: 1 fullname: 地引, 政利 organization: 東京医科歯科大学血管外科 – sequence: 1 fullname: 豊福, 崇浩 organization: 東京医科歯科大学血管外科 – sequence: 1 fullname: 井上, 芳徳 organization: 東京医科歯科大学血管外科 – sequence: 1 fullname: 工藤, 敏文 organization: 東京医科歯科大学血管外科 |
BookMark | eNo9kE1LAkEAhocwyMxL_2NtvtadOUVIX2B0qWMss7tjuZjFrheP7hoaHoIoI6hAb2aYl6Ag_DPDaP6LNopOz-F5eQ_PMkhVz6oSgFUEcxYiZM13Rc7EOUzJAkgjxqDBGIUpkIaEWQZCOL8EsmFYdiCEnELCrTQ40r3B_OJdRW8qHqr4UUVjFb-oeKDiTxW3VWOooraKOtOH4bTf153br2Z73r3UvafZXSux-nWiGvfJQE9GenylJ8-z67FqjKY3H7rbXAGLJVEJZfaPGXC4tXlQ2DGK-9u7hY2i4WNIhOG4BEnLdRxmeZRKivMlTDnnbkl4DuaOSU1pMpdLiqBAHoceRQJ7xJQWw3nokAxY__31w5o4lvZ5UD4VQd0WQa3sVqSdlLFNbO-J-g-SQP_GPRGB7QvyDXO8gVE |
ContentType | Journal Article |
Copyright | 2012 日本脈管学会 |
Copyright_xml | – notice: 2012 日本脈管学会 |
DOI | 10.7133/jca.52.243 |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 1880-8840 |
EndPage | 246 |
ExternalDocumentID | article_jca_52_May_52_243_article_char_ja |
GroupedDBID | ALMA_UNASSIGNED_HOLDINGS JSF KQ8 RJT |
ID | FETCH-LOGICAL-j203a-bc31e7cbb87d44e426f24999cfadb29b545e58c9e410a1d90d41a2d35e78260b3 |
ISSN | 0387-1126 |
IngestDate | Wed Sep 03 06:30:56 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | May |
Language | Japanese |
License | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.ja |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-j203a-bc31e7cbb87d44e426f24999cfadb29b545e58c9e410a1d90d41a2d35e78260b3 |
OpenAccessLink | https://www.jstage.jst.go.jp/article/jca/52/May/52_243/_article/-char/ja |
PageCount | 4 |
ParticipantIDs | jstage_primary_article_jca_52_May_52_243_article_char_ja |
PublicationCentury | 2000 |
PublicationDate | 2012/05/10 |
PublicationDateYYYYMMDD | 2012-05-10 |
PublicationDate_xml | – month: 05 year: 2012 text: 2012/05/10 day: 10 |
PublicationDecade | 2010 |
PublicationTitle | 脈管学 |
PublicationTitleAlternate | 脈管学 |
PublicationYear | 2012 |
Publisher | 日本脈管学会 |
Publisher_xml | – name: 日本脈管学会 |
References | 6)Hara H, Kitajima A, Shimada H, et al: Antithrombotic effect of MCI-9042, a new antiplatelet agent on experimental thrombosis models. Thromb Haemost 1991; 66: 484-488 20)Greenwald RA: The "doctor's letter"-what is our obligation? N Engl J Med 1991; 324: 64 3)Wright L, Homans DC, Laxson DD, et al: Effect of serotonin and thromboxane A2 on blood flow through moderately well developed coronary collateral vessels. J Am Coll Cardiol 1992; 19: 687-693 15)Castronuovo JJ, Pabst TS, Flanigan DP, et al: Noninvasive determination of skin perfusion pressure using a laser Doppler. J Cardiovasc Surg (Torino) 1987; 28: 253-257 1)Norgren L, Hiatt WR, Dormandy JA, et al: Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 2007; 33 (Suppl 1): S1-S75 19)Doggrell SA: Sarpogrelate: cardiovascular and renal clinical potential. Expert Opin Investig Drugs 2004; 13: 865-874 22)Matsuo H, Shigematsu H: Effects of the 5-HT2A antagonist sarpogrelate hydrochloride on walking ability in patients with intermittent claudication as measured using the walking impairment questionnaire. Ann Vasc Dis 2008; 1: 102-110 11)Lalka SG, Malone JM, Anderson GG, et al: Transcutaneous oxygen and carbon dioxide pressure monitoring to determine severity of limb ischemia and to predict surgical outcome. J Vasc Surg 1988; 7: 507-514 13)Mathieu D, Mani R: A review of the clinical significance of tissue hypoxia measurements in lower extremity wound management. Int J Low Extrem Wounds 2007; 6: 273-283 18)Cina C, Katsamouris A, Megerman J, et al: Utility of transcutaneous oxygen tension measurements in peripheral arterial occlusive disease. J Vasc Surg 1984; 1: 362-371 23)磯貝行秀,横瀬琢男,池本 卓,他:塩酸サルポグレラート(MCI-9042)の第I相臨床試験─単回および連続経口投与試験─.臨床医薬 1991; 7: 1177-1192 5)Nakamura K, Kariyazono H, Moriyama Y, et al: Effects of sarpogrelate hydrochloride on platelet aggregation, and its relation to the release of serotonin and P-selectin. Blood Coagul Fibrinolysis 1999; 10: 513-519 9)Yamakawa J, Takahashi T, Saegusa S, et al: Effect of the serotonin blocker sarpogrelate on circulating interleukin-18 levels in patients with diabetes and arteriosclerosis obliterans. J Int Med Res 2004; 32: 166-169 10)Ballard JL, Eke CC, Bunt TJ, et al: A prospective evaluation of transcutaneous oxygen measurements in the management of diabetic foot problems. J Vasc Surg 1995; 22: 485-490; discussion 490-492 7)Yamashita T, Kitamori K, Hashimoto M, et al: Conjunctive effects of the 5HT(2) receptor antagonist, sarpogrelate, on thrombolysis with modified tissue plasminogen activator in different laser-induced thrombosis models. Haemostasis 2000; 30: 321-332 8)Norgren L, Jawien A, Mátyás L, et al: Sarpogrelate, a 5-hT2A receptor antagonist in intermittent claudication. A phase II European study. Vasc Med 2006; 11: 75-83 17)Bacharach JM, Rooke TW, Osmundson PJ, et al: Predictive value of transcutaneous oxygen pressure and amputation success by use of supine and elevation measurements. J Vasc Surg 1992; 15: 558-563 21)Miyazaki M, Higashi Y, Goto C, et al: Sarpogrelate hydrochloride, a selective 5-HT2A antagonist, improves vascular function in patients with peripheral arterial disease. J Cardiovasc Pharmacol 2007; 49: 221-227 4)Hara H, Osakabe M, Kitajima A, et al: MCI-9042, a new antiplatelet agent is a selective S2-serotonergic receptor antagonist. Thromb Haemost 1991; 65: 415-420 14)Ubbink DT, Jacobs MJ, Tangelder GJ, et al: The usefulness of capillary microscopy, transcutaneous oximetry and laser Doppler fluxmetry in the assessment of the severity of lower limb ischaemia. Int J Microcirc Clin Exp 1994; 14: 34-44 2)Barradas MA, Gill DS, Fonseca VA, et al: Intraplatelet serotonin in patients with diabetes mellitus and peripheral vascular disease. Eur J Clin Invest 1988; 18: 399-404 16)Beran AV, Tolle CD, Huxtable RF: Cutaneous blood flow and its relationship to transcutaneous O2/CO2 measurements. Crit Care Med 1981; 9: 736-741 12)Ubbink DT, Tulevski II, den Hartog D, et al: The value of non-invasive techniques for the assessment of critical limb ischaemia. Eur J Vasc Endovasc Surg 1997; 13: 296-300 |
References_xml | – reference: 3)Wright L, Homans DC, Laxson DD, et al: Effect of serotonin and thromboxane A2 on blood flow through moderately well developed coronary collateral vessels. J Am Coll Cardiol 1992; 19: 687-693 – reference: 21)Miyazaki M, Higashi Y, Goto C, et al: Sarpogrelate hydrochloride, a selective 5-HT2A antagonist, improves vascular function in patients with peripheral arterial disease. J Cardiovasc Pharmacol 2007; 49: 221-227 – reference: 13)Mathieu D, Mani R: A review of the clinical significance of tissue hypoxia measurements in lower extremity wound management. Int J Low Extrem Wounds 2007; 6: 273-283 – reference: 5)Nakamura K, Kariyazono H, Moriyama Y, et al: Effects of sarpogrelate hydrochloride on platelet aggregation, and its relation to the release of serotonin and P-selectin. Blood Coagul Fibrinolysis 1999; 10: 513-519 – reference: 16)Beran AV, Tolle CD, Huxtable RF: Cutaneous blood flow and its relationship to transcutaneous O2/CO2 measurements. Crit Care Med 1981; 9: 736-741 – reference: 23)磯貝行秀,横瀬琢男,池本 卓,他:塩酸サルポグレラート(MCI-9042)の第I相臨床試験─単回および連続経口投与試験─.臨床医薬 1991; 7: 1177-1192 – reference: 8)Norgren L, Jawien A, Mátyás L, et al: Sarpogrelate, a 5-hT2A receptor antagonist in intermittent claudication. A phase II European study. Vasc Med 2006; 11: 75-83 – reference: 18)Cina C, Katsamouris A, Megerman J, et al: Utility of transcutaneous oxygen tension measurements in peripheral arterial occlusive disease. J Vasc Surg 1984; 1: 362-371 – reference: 14)Ubbink DT, Jacobs MJ, Tangelder GJ, et al: The usefulness of capillary microscopy, transcutaneous oximetry and laser Doppler fluxmetry in the assessment of the severity of lower limb ischaemia. Int J Microcirc Clin Exp 1994; 14: 34-44 – reference: 10)Ballard JL, Eke CC, Bunt TJ, et al: A prospective evaluation of transcutaneous oxygen measurements in the management of diabetic foot problems. J Vasc Surg 1995; 22: 485-490; discussion 490-492 – reference: 22)Matsuo H, Shigematsu H: Effects of the 5-HT2A antagonist sarpogrelate hydrochloride on walking ability in patients with intermittent claudication as measured using the walking impairment questionnaire. Ann Vasc Dis 2008; 1: 102-110 – reference: 6)Hara H, Kitajima A, Shimada H, et al: Antithrombotic effect of MCI-9042, a new antiplatelet agent on experimental thrombosis models. Thromb Haemost 1991; 66: 484-488 – reference: 15)Castronuovo JJ, Pabst TS, Flanigan DP, et al: Noninvasive determination of skin perfusion pressure using a laser Doppler. J Cardiovasc Surg (Torino) 1987; 28: 253-257 – reference: 2)Barradas MA, Gill DS, Fonseca VA, et al: Intraplatelet serotonin in patients with diabetes mellitus and peripheral vascular disease. Eur J Clin Invest 1988; 18: 399-404 – reference: 1)Norgren L, Hiatt WR, Dormandy JA, et al: Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 2007; 33 (Suppl 1): S1-S75 – reference: 19)Doggrell SA: Sarpogrelate: cardiovascular and renal clinical potential. Expert Opin Investig Drugs 2004; 13: 865-874 – reference: 9)Yamakawa J, Takahashi T, Saegusa S, et al: Effect of the serotonin blocker sarpogrelate on circulating interleukin-18 levels in patients with diabetes and arteriosclerosis obliterans. J Int Med Res 2004; 32: 166-169 – reference: 20)Greenwald RA: The "doctor's letter"-what is our obligation? N Engl J Med 1991; 324: 64 – reference: 11)Lalka SG, Malone JM, Anderson GG, et al: Transcutaneous oxygen and carbon dioxide pressure monitoring to determine severity of limb ischemia and to predict surgical outcome. J Vasc Surg 1988; 7: 507-514 – reference: 4)Hara H, Osakabe M, Kitajima A, et al: MCI-9042, a new antiplatelet agent is a selective S2-serotonergic receptor antagonist. Thromb Haemost 1991; 65: 415-420 – reference: 17)Bacharach JM, Rooke TW, Osmundson PJ, et al: Predictive value of transcutaneous oxygen pressure and amputation success by use of supine and elevation measurements. J Vasc Surg 1992; 15: 558-563 – reference: 7)Yamashita T, Kitamori K, Hashimoto M, et al: Conjunctive effects of the 5HT(2) receptor antagonist, sarpogrelate, on thrombolysis with modified tissue plasminogen activator in different laser-induced thrombosis models. Haemostasis 2000; 30: 321-332 – reference: 12)Ubbink DT, Tulevski II, den Hartog D, et al: The value of non-invasive techniques for the assessment of critical limb ischaemia. Eur J Vasc Endovasc Surg 1997; 13: 296-300 |
SSID | ssib000940397 ssib005879700 ssib051641554 ssj0002920462 ssib002227066 ssib058493671 ssib050995460 |
Score | 1.902105 |
Snippet | 塩酸サルポグレラートが末梢循環に及ぼす影響を評価した。末梢動脈閉塞症13例を対象とし,非服用時の患肢足背部の経皮酸素分圧(tcPO2)値が50 mmHg未満12肢(A群)と50 mmHg以... |
SourceID | jstage |
SourceType | Publisher |
StartPage | 243 |
SubjectTerms | 5-HT2A receptor blocker collateral key words:5-hydroxytryptamine (5-HT) microcirculation vascular spasm |
Title | 塩酸サルポグレラートによる末梢動脈閉塞症に対する微小循環の改善 |
URI | https://www.jstage.jst.go.jp/article/jca/52/May/52_243/_article/-char/ja |
Volume | 52 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | 脈管学, 2012/05/10, Vol.52(May), pp.243-246 |
journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1880-8840 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0002920462 issn: 0387-1126 databaseCode: KQ8 dateStart: 20120101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1880-8840 dateEnd: 99991231 omitProxy: true ssIdentifier: ssib051641554 issn: 0387-1126 databaseCode: M~E dateStart: 19610101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1Na9RANNR68SKKit_04BxTk8lMZuaYbFOKUE8t9CIhM0kPe6gi7aUHobsVKz0IohVBhfZWK7UXQUH2twghrf0Xvpkku6OI1MKSfbx58-Z9JPvezM68OM4dxZlSQhE39AhxScYCV-ZEuZDpQnAoSF4s6vPOs_fDmXlyb4EujJ35Ye1aWlmWk2r1r-dKTuNVwIFf9SnZ__DskCkgAAb_whU8DNcT-RglFEU-igRKBOIUxRwlAeIYxdQAAYriBhBTbZPXNnVaQDRA3GJ4zcdvu-MWAwBgQiQ6pilEEdYfEAPwAgbliBNDLJAIEReNhCJBCUOCIc4sztA0jeKkwQhhDUE1PkoM4CE-3WIiw2eohW9oQB6CYjOWHpTYCbclEtPEIIwedwpFwyVJ069jWFJtA9AD7ruWrRkaukdiRM9R7CNuZIlCLZ2hh87EKBhq-9v0wCYy5iHaRdDR0BsoDhrV4sCWJwbOxpxgs4gM5aHGFKFRk9kLNnrni671OnzEDFXNpHZX5x-WMIKB4pEVFnQ1ZH3wq47gddiCX2GX87rwVRvXKLae39lmS1YTpurSWE3Gg-tF4D-DqV6-0MFUZZMUTw67_FacvLn1UyBKKU5hFP0FtGnbog8Ppl2YwZzFLAz1O0ZmnyRWgk-8QNgLCpjZ7xegnAmrgCRkt4KS0YSewmTfToghmxZBW7BR52L6XWwkrP9KbMxW1yjWyt0dqQb5ZxdmY-1OTpNczl1wzjezwomo1uaiM9bNLjkPqu3d46dfy96Xsr9X9t-XvYOy_6ns75b972V_o1zbK3sbZW_z8N3e4c5Otfn65_rG8dbzavvD0Ztn0Fp9HpRrb4GgGuxXBy-qwcejlwfl2v7hq2_V1vplZ346mevMuM3bUNwu9oLMlSrwC6ak5CwnpIDMehHr5Qq1mOUSCwlToYJyJQrie5mfCy8nfobzgBYwCQg9GVxxxpceLhVXnYkccnolA8GFX0AMl9Jj2Ct8X_lEekTQaw6vrZE-qkvepCf28_XTd73hnBs9Ljed8eXHK8UtyPiX5W1z0_wC68jV8g |
linkProvider | ISSN International Centre |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E5%A1%A9%E9%85%B8%E3%82%B5%E3%83%AB%E3%83%9D%E3%82%B0%E3%83%AC%E3%83%A9%E3%83%BC%E3%83%88%E3%81%AB%E3%82%88%E3%82%8B%E6%9C%AB%E6%A2%A2%E5%8B%95%E8%84%88%E9%96%89%E5%A1%9E%E7%97%87%E3%81%AB%E5%AF%BE%E3%81%99%E3%82%8B%E5%BE%AE%E5%B0%8F%E5%BE%AA%E7%92%B0%E3%81%AE%E6%94%B9%E5%96%84&rft.jtitle=%E8%84%88%E7%AE%A1%E5%AD%A6&rft.au=%E5%9C%B0%E5%BC%95%2C+%E6%94%BF%E5%88%A9&rft.au=%E8%B1%8A%E7%A6%8F%2C+%E5%B4%87%E6%B5%A9&rft.au=%E4%BA%95%E4%B8%8A%2C+%E8%8A%B3%E5%BE%B3&rft.au=%E5%B7%A5%E8%97%A4%2C+%E6%95%8F%E6%96%87&rft.date=2012-05-10&rft.pub=%E6%97%A5%E6%9C%AC%E8%84%88%E7%AE%A1%E5%AD%A6%E4%BC%9A&rft.issn=0387-1126&rft.eissn=1880-8840&rft.volume=52&rft.issue=May&rft.spage=243&rft.epage=246&rft_id=info:doi/10.7133%2Fjca.52.243&rft.externalDocID=article_jca_52_May_52_243_article_char_ja |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0387-1126&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0387-1126&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0387-1126&client=summon |